Vertex Pharmaceuticals Incorporated Analysis
| Analyst Ratings |
|
Average Target Price
|
324.70
|
|
Average Rating
|
3.96
|
|
# Strong Buys
|
10
|
|
# Buys
|
7
|
|
# Holds
|
11
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
3.64
|
4.01
|
0.37
|
10.16%
|
|
2022-06-30
|
3.48
|
3.60
|
0.12
|
3.45%
|
|
2022-03-31
|
3.49
|
3.52
|
0.03
|
0.86%
|
|
2021-12-31
|
3.30
|
3.37
|
0.07
|
2.12%
|
|
2021-09-30
|
3.08
|
3.56
|
0.48
|
15.58%
|
|
2021-06-30
|
2.51
|
3.11
|
0.60
|
23.90%
|
|
2021-03-31
|
2.69
|
2.98
|
0.29
|
10.78%
|
|
2020-12-31
|
2.59
|
2.51
|
-0.08
|
-3.09%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
11.13
|
|
2021-12-31
|
13.02
|
|
2020-12-31
|
10.32
|
|
2019-12-31
|
5.33
|
|
2018-12-31
|
4.09
|
|
2017-12-31
|
1.94
|
|
2016-12-31
|
0.84
|
|
2015-12-31
|
-1.12
|
|
2014-12-31
|
-3.14
|
|
2013-12-31
|
-0.72
|
|
2012-12-31
|
0.13
|
|
2011-12-31
|
0.04
|
|
2010-12-31
|
-3.77
|
|
2009-12-31
|
-3.72
|
|
2008-12-31
|
-3.27
|
|
2007-12-31
|
-3.03
|
|
2006-12-31
|
-1.87
|
|
2005-12-31
|
-2.28
|
|
2004-12-31
|
-2.11
|
|
2003-12-31
|
-2.33
|
|
2002-12-31
|
-1.41
|
|
2001-12-31
|
-0.64
|
|
2000-12-31
|
-0.59
|
|
1999-12-31
|
-0.80
|
|
1998-12-31
|
-0.64
|
|
1997-12-31
|
-0.40
|
|
1996-12-31
|
-0.67
|